It is a member of the human epidermal receptor (HER) family and an important component of the cellular signaling pathway, and the upregulation of both EGFR gene and protein expression levels activate downstream pathways that are associated with cancer progression (Huang and Fu, 2015). The gene discussed is EGFR; the disease is cancer.